Top Markets
Coin of the day
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp.

PBAX
Rank in Stocks #15371
Phoenix Biotech Acquisition Corp. currently lacks substantial business... Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Share Price
$5.85
Last synced: 2024-02-14
Market Cap
$356.42M
Change (1 day)
4.65%
Change (1 year)
0.00%
Country
US
Trade Phoenix Biotech Acquisition Corp. (PBAX)
Revenue for Phoenix Biotech Acquisition Corp. (PBAX)
Revenue in Sep 2026 TTM: 0
According to Phoenix Biotech Acquisition Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Phoenix Biotech Acquisition Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors